GlobalData on MSN
GE HealthCare secures FDA 510(k) clearance for diagnostic viewer
View offers 2D and 3D visualisation, along with AI-based tools, to assist in clinical decision making.
Modern Engineering Marvels on MSN
X-ray view of interstellar comet 3I/ATLAS exposes its solar wind boundary
An interstellar comet can glow in X-rays even while remaining hundreds of millions of kilometers away. That is what makes 3I/ATLAS unusually valuable to astronomers. The object, only the third known ...
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the Best Young Stocks To Buy and Hold For 20 Year. On March 9, GE HealthCare Technologies Inc. (NASDAQ:GEHC) announced FDA 510(k) clearance for ...
Michael Bernstein, MD, discusses how AI-assisted radiology workflows affect liability, automation bias, and patient safety in diagnostic imaging. As artificial intelligence (AI) becomes more embedded ...
An exhibit at New York's Museum of the Moving Image explores how medical imaging technologies like CT scans and X-rays have reshaped our view of the body — and ourselves.
View streamlines imaging analysis and visualization by using a suite of AI-enabled tools intended to aid clinical decision making.
Zacks Investment Research on MSN
GEHC wins FDA 510(k) approval for View, enhances radiology workflows
GE HealthCare Technologies Inc. GEHC recently announced that the FDA has granted 510(k) clearance for View, a next-generation diagnostic imaging viewer within its Genesis Radiology Workspace. For ...
Stockhead on MSN
Friend not foe: ASX health imaging firms see opportunity in AI
ASX health imaging firms see AI as opportunity, not threat, with growth potential intact despite recent sell down in software ... Read More The post Friend not foe: ASX health imaging firms see ...
In an interview, Vincent Ma, MD, explores the clinical utility of circulating tumor DNA dynamics to assess early outcomes in ...
Despite record revenue growth and a swelling pipeline of US contracts, Pro Medicus shares have been caught in the market’s ...
Regulatory expansion positions deucravacitinib 6 mg once daily as a first-in-class oral TYK2 option for active PsA, complementing its prior plaque psoriasis indication. POETYK PsA-1 showed significant ...
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health systems connect continuous patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results